<DOC>
	<DOCNO>NCT00777361</DOCNO>
	<brief_summary>This study perform order learn new drug ( possible treatment people Alzheimer 's Disease condition cognitive dysfunction ( memory attention problem ) ) handle body give drug healthy volunteer different genotype .</brief_summary>
	<brief_title>Study Uptake , Break Down Elimination Investigational Drug Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Physically healthy volunteer Participation previous study genotyping identification extensive , intermediate poor metaboliser ( CYP2D6 enzyme ) History clinically significant disease illness . Ues prescribe nonprescribed medication 2 week prior first treatment day except paracetamol OTC adrenergic nasal spray .</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Mass balance</keyword>
	<keyword>AZD3480 , Pharmacokinetics , Healthy volunteer</keyword>
</DOC>